William Harvey Research Institute, Faculty of Medicine and Dentistry, Barts & The London, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
William Harvey Research Institute, Faculty of Medicine and Dentistry, Barts & The London, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
Pharmacol Ther. 2024 Oct;262:108708. doi: 10.1016/j.pharmthera.2024.108708. Epub 2024 Aug 21.
C-type natriuretic peptide (CNP) represents the 'local' member of the natriuretic peptide family, functioning in an autocrine or paracrine capacity to modulate a hugely diverse portfolio of physiological processes. Whilst the best-characterised of these regulatory roles are in the cardiovascular system, akin to its predominantly endocrine siblings atrial (ANP) and brain (BNP) natriuretic peptides, CNP governs many additional, unrelated mechanisms including bone growth, gamete maturation, auditory processing, and neuronal integrity. Furthermore, there is currently great interest in mimicking the biological activity of CNP for therapeutic gain in many of these disparate organ systems. Herein, we provide an overview of the physiology, pathophysiology and pharmacology of CNP in both cardiovascular and non-cardiovascular settings.
C 型利钠肽(CNP)是利钠肽家族中的“局部”成员,以自分泌或旁分泌的方式发挥作用,调节着极其多样化的生理过程。虽然这些调节作用中研究得最好的是在心血管系统中,类似于其主要的内分泌兄弟心房(ANP)和脑(BNP)利钠肽,但 CNP 还控制着许多其他不相关的机制,包括骨骼生长、配子成熟、听觉处理和神经元完整性。此外,目前人们对模仿 CNP 的生物学活性以在许多这些不同的器官系统中获得治疗益处非常感兴趣。在此,我们提供了 CNP 在心血管和非心血管环境中的生理学、病理生理学和药理学概述。